Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.86
-2.40 (-4.27%)
At close: Aug 6, 2026, 4:00 PM EDT
54.58
+0.72 (1.33%)
After-hours: Aug 6, 2026, 7:59 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $21.5 billion as of August 6, 2026. Its market cap has increased by 101.19% in one year.
Market Cap
21.50B
Enterprise Value
15.88B
1-Year Change
101.19%
Ranking
Category
Stock Price
$53.86
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $21.50B, an increase of 251.44%. That is a compound annual growth rate of 17.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 21.50B | 86.61% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 32.97B |
| Alnylam Pharmaceuticals | 28.92B |
| Insmed | 28.73B |
| Roivant Sciences | 25.26B |
| Incyte | 24.00B |
| BioNTech SE | 22.91B |
| Genmab | 17.94B |
| Jazz Pharmaceuticals | 16.66B |